Rafferty Asset Management, LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.

Quarter-by-quarter ownership
Rafferty Asset Management, LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,992,100
+20.8%
74,180
+14.1%
0.05%
+26.2%
Q2 2023$7,444,258
+11.0%
65,004
+33.6%
0.04%
-6.7%
Q1 2023$6,704,878
-26.7%
48,646
-31.1%
0.04%
-41.6%
Q4 2022$9,152,754
+36.1%
70,634
+16.1%
0.08%
+6.9%
Q3 2022$6,724,000
+48.7%
60,831
+0.8%
0.07%
+71.4%
Q2 2022$4,522,000
-21.7%
60,327
-18.4%
0.04%
+23.5%
Q1 2022$5,773,000
-3.0%
73,893
+11.8%
0.03%
+9.7%
Q4 2021$5,953,000
+45.1%
66,111
+49.0%
0.03%
+10.7%
Q3 2021$4,102,000
+74.0%
44,359
+46.2%
0.03%
+86.7%
Q2 2021$2,358,000
-17.9%
30,332
-21.3%
0.02%
-25.0%
Q1 2021$2,871,000
+202.2%
38,524
+591.1%
0.02%
+122.2%
Q4 2020$950,000
-55.4%
5,574
-63.3%
0.01%
-65.4%
Q3 2020$2,132,000
+118.9%
15,181
+150.0%
0.03%
+85.7%
Q2 2020$974,000
+177.5%
6,072
+69.1%
0.01%
-6.7%
Q1 2020$351,000
-90.9%
3,590
-88.0%
0.02%
-74.6%
Q4 2019$3,849,000
-32.3%
29,828
-60.5%
0.06%
-33.7%
Q3 2019$5,688,000
-9.5%
75,514
+82.6%
0.09%
-19.1%
Q2 2019$6,283,000
+39.0%
41,347
+9.1%
0.11%
+50.7%
Q1 2019$4,519,00037,9140.07%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 112,689$14,541,00014.93%
Casdin Capital, LLC 670,000$86,457,0007.95%
Logos Global Management LP 226,002$29,163,0007.19%
Avoro Capital Advisors LLC 1,760,000$227,110,0006.67%
Camber Capital Management LP 600,000$77,424,0003.94%
STANSBERRY ASSET MANAGEMENT, LLC 71,133$9,179,0003.74%
Eventide Asset Management 996,000$128,524,0003.62%
CADIAN CAPITAL MANAGEMENT, LP 550,000$70,972,0003.14%
RTW INVESTMENTS, LP 605,762$78,168,0002.95%
Consonance Capital Management LP 356,145$45,957,0002.80%
View complete list of SAREPTA THERAPEUTICS INC shareholders